As e-commerce market is booming in India, online sale of medicines also getting popularity and some of the online medicine seller like PharmEasy, Orbimed, and Netmeds attracted huge foreign investment from venture capitalists. But Drug Controller General of India (DGCI) imposed a ban on it, and obviously, it is a major setback for e-pharmacies.
Interestingly last year on the 30th annual conference of Indian Graduates’ Association (IPGA) at Air Force Auditorium, New Delhi 31th October 2015 DGCI (Drug Controller General of India) Dr. G. N. Sing had said that they were considering modifying the Drugs and Cosmetics Act for the online sale of medicine. But, just after two-month DGCI have taken a U-turn and imposed a ban on the online sale of medicines on 30 December 2015 and circulate a directive to all State and Union Territory Drugs Controllers.
The cause of ban on the online sale of medicines was that many organizations, individuals, and trade body revealed some serious issues impacting public health such as gross violation of Drug and Cosmetic Act and Rule like a risk of human lives, compromise of drug storage conditions, can increase drug addiction among youth etc.
DGCI (Drug Controller General of India) also constituted a sub-committee under the chairmanship of Dr. Harshadeep Kamble to examine the issues and impact on public health and will decide after receiving of the sub-committee report.
We have to wait for Drug Controller General of India’s next directive for this issue.